MedPath

Acute biliary Pancreatitis: early Endoscopic retrograde cholangiography plus sphincterotomy versus Conservative treatment (APEC trial)

Not Applicable
Completed
Conditions
Acute biliary pancreatitis
Biliary acute pancreatitis
Digestive System
Registration Number
ISRCTN97372133
Lead Sponsor
Erasmus Medical Center (Netherlands)
Brief Summary

2016 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/26729193 2020 results in https://pubmed.ncbi.nlm.nih.gov/32682482/ (added 21/07/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
232
Inclusion Criteria

1. Acute biliary pancreatitis
2. Predicted severe disease course
3. ERC with sphincterotomy can be performed within 24 hours after admission
4. Age > 18 years
5. Written informed consent
6. In case of a previous episode of necrotizing pancreatitis, patient should be fully recovered

Exclusion Criteria

1. Cholangitis
2. Acute pancreatitis due to other causes such as alcohol abuse, metabolic causes, medication, trauma, etc.
3. Previous (precut) sphincterotomy
4. Chronic pancreatitis
5. INR that cannot be corrected with co-fact or fresh frozen plasma below 1.5
6. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> A composite of severe morbidity and mortality occurring until 6 months after randomization.<br><br> Severe morbidity is defined as the occurrence of persistent single organ failure, necrotizing pancreatitis, bacteremia, cholangitis, pneumonia or exocrine or endocrine pancreatic insufficiency.<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Individual components of the primary endpoint<br> 2. Length of hospital stay<br> 3. Need for of new intensive care admission<br> 4. Length of intensive care stay<br> 5. Respiratory complications<br> 6. ERC related complications<br> 7. Number of endoscopic, radiological and operative (re-)interventions<br> 8. Readmission for biliary events<br> 9. Difficulty of cholecystectomy<br> 10. Economical evaluation<br>
© Copyright 2025. All Rights Reserved by MedPath